Avsar.
MA

Healthcare · Pharmaceuticals

Makers Laboratories Ltd (MAKERSL)

₹182.35

Mkt cap
₹113 Cr
P/E ratio
33.00
P/B
1.47
Div yield
0.00%
ROE
3.17%
ROCE
9.28%
EPS (TTM)
₹5.53
Book value
₹124
52W range
150–236
Sector
Healthcare

Price history

Previous close

Incorporated in 1984, Makers Laboratories Ltd manufactures and markets around 200 pharma formulations. [1]

NSE MAKERSLBSE 506919
Health check
Cautious
ValuationFair
ProfitabilityWeak
GrowthModerate
TechnicalsNeutral
52-week range
−22.73% from high
₹182
₹150+21.57% from low₹236
Current
₹182.35
Prev close
₹179.95
Day
+1.33%
Price performance
1D
+1.33%
1W
+0.67%
1M
−9.17%
3M
—
6M
—
1Y
—
YTD
+19.50%

Financials

Revenue, profit & margin
P/E ratio
33.0×
MAKERSL is 5% below the sector median of 34.6×
MAKERSL33.0×
Sector median34.6×
 Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Trend
Sales25.0125.0626.5127.8129.5929.5727.6933.9035.0034.1735.6735.7542.77
Expenses25.1524.8626.3126.9527.7827.3826.3830.8131.9931.8931.5130.4735.81
Operating Profit-0.140.200.200.861.812.191.313.093.012.284.165.286.96
OPM %-0.56%0.80%0.75%3.09%6.12%7.41%4.73%9.12%8.60%6.67%11.66%14.77%16.27%
Other Income0.250.410.370.43-0.5110.630.870.100.270.360.330.760.61
Interest0.410.490.530.520.490.430.190.180.180.220.200.170.15
Depreciation1.111.131.161.151.281.291.310.901.121.131.141.131.13
Profit before tax-1.41-1.01-1.12-0.38-0.4711.100.682.111.981.293.154.746.29
Tax %18.44%10.89%-4.46%152.63%48.94%11.98%60.29%24.64%34.85%42.64%27.94%24.89%27.03%
Net Profit-1.66-1.13-1.06-0.97-0.709.760.271.581.290.742.273.564.59
EPS in Rs-3.56-2.27-2.61-2.19-1.6614.95-0.51-0.080.75-0.201.591.852.54
Raw PDF

Earnings

Results dates & reactions
No upcoming results date on calendar.

Fresh quarters land in the Financials table above, tagged NSE until screener catches up.

No reaction history yet.
No quarterly filings ingested yet.

Corporate actions

Last 6 months

No recent corporate actions

Dividends, splits, and bonuses in the last six months show up here.

Shareholding

as of Jun 2026
61.28%Promoter
Promoters61.28%
DIIs0.39%
Public38.34%
Ownership trend

Peers

8 companies
Valuation vs quality
P/E × ROCE · bubble = market cap
NameCMPP/EMkt CapDiv YldNP QtrQtr Profit VarSales QtrQtr Sales VarROCE
Sun Pharma.Inds.₹1,837.3034.904,40,8300.87%2,901+5.95%15,300+10.46%20.53%
Divi's Lab.₹9,375.0083.542,48,8770.32%902+65.50%3,080+27.80%21.97%
Torrent Pharma.₹4,840.0082.511,84,0980.79%566+5.79%4,921+54.85%15.19%
Zydus Lifesci.₹1,160.0023.771,15,7100.09%990−35.09%8,017+21.96%21.14%
Cipla₹1,394.5031.481,12,6560.93%786−39.19%7,119+2.33%15.49%
Laurus Labs₹1,954.0096.561,05,5770.10%362+125.49%2,026+29.10%17.76%
Aurobindo Pharma₹1,734.0026.3999,7710.23%1,032+28.11%9,150+16.30%12.86%
Makers Labs.₹190.8833.031130.00%5+240.91%43+22.20%9.28%
Median: 158 Co.₹433.9034.562,2050.08%13+29.57%164+18.57%14.96%

Filings

Annual reports15
Annual Report 2026Annual Report 2025Annual Report 2024Annual Report 2023Annual Report 2022Annual Report 2021Annual Report 2020Annual Report 2019Annual Report 2018Annual Report 2017Annual Report 2016Annual Report 2015Annual Report 2014Annual Report 2013Annual Report 2012
Credit ratings6
Rating update 4 SepcareRating update 3 Sep 2025careRating update 8 Oct 2024careRating update 5 Feb 2024careRating update 8 Mar 2023careRating update 24 Mar 2022care
Announcements5
Announcement under Regulation 30 (LODR)-Newspaper Publication 17 SepShareholder Meeting / Postal Ballot-Notice of Postal Ballot 10 SepAnnouncement under Regulation 30 (LODR)-Credit Rating 1 Sep - CARE Edge reaffirmed BBB+ Stable rating for Rs 8 crore long-term bank facilities.Announcement under Regulation 30 (LODR)-Newspaper Publication 10 AugShareholder Meeting / Postal Ballot-Scrutinizer''s Report 7 Aug